Cahill Financial Advisors Inc Glaukos Corp Transaction History

Cahill Financial Advisors Inc

  • $707 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$70.43 - $97.42 $257,139 - $355,680
-3,651 Closed
0 $0
Q4 2020

Feb 17, 2021
SELL
$48.9 - $75.26 $26,406 - $40,640
-540 Reduced 12.88%
3,651 $275,000
Q3 2020

Nov 17, 2020
BUY
$37.23 - $50.97 $156,030 - $213,615
4,191 New
4,191 $208,000

Others Institutions Holding GKOS

# of Institutions
342
Shares Held
46.8M
Call Options Held
132K
Put Options Held
188K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.45B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Cahill Financial Advisors Inc Portfolio

Follow Cahill Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cahill Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cahill Financial Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email